CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE11734.75-375.15 (-3.1 %)
PREV CLOSE () 12109.90
OPEN PRICE () 12116.40
BID PRICE (QTY) 11756.20 (1)
OFFER PRICE (QTY) 11793.50 (1)
VOLUME 1299
TODAY'S LOW / HIGH ()11540.50 12208.75
52 WK LOW / HIGH ()3612.05 13600
NSE11704.85-372.15 (-3.08 %)
PREV CLOSE() 12077.00
OPEN PRICE () 12105.00
BID PRICE (QTY) 11710.40 (5)
OFFER PRICE (QTY) 11741.10 (4)
VOLUME 12560
TODAY'S LOW / HIGH() 11529.95 12247.10
52 WK LOW / HIGH ()3611.1 13630
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office :

Address : 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone : 040-67611600 / 67611700

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
01Aug Neuland Laboratories informs about ana
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
24Jul Neuland Laboratories informs about ear
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
21Jun Neuland Laboratories informs about los
Neuland Laboratories has informed that the Company has approved issuance..
18Jun Neuland Laboratories informs about inv
Neuland Laboratories has informed that the Company’s management will be..
10Jun Neuland Laboratories informs about pre
Neuland Laboratories has informed that it enclosed Press Release dated J..
Financials
in Millions
QTR Jun 24 ANNUAL 24
Net Profit983.392995.96
Gross Profit 1303.09 4007.69
Operating Profit 1286.334744.65
Net Sales 4396.0215585.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 7766.45 (4.49%)
M.Cap ( in Cr)
19440.00
RPG Life Sciences (BSE)
 2662.00 (1.93%)
M.Cap ( in Cr)
4242.26
Alkem Laboratories (BSE)
 6236.05 (0.63%)
M.Cap ( in Cr)
73928.83
Natco Pharma (BSE)
 1385.85 (2.30%)
M.Cap ( in Cr)
24389.39
Divi's Lab (BSE)
 5451.60 (0.54%)
M.Cap ( in Cr)
143367.63
Shareholding Pattern
NON-INSTITUTION 34.76%
PROMOTERS 32.72%
MUTUAL FUNDS/UTI 4.07%
GOVERNMENT 0.4%
FI/BANKS/INSURANCE 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX81648.32-40.13 (-0.05%)
NIFTY24902.45-112.15 (-0.45%)
Dow Jones 42352.75341.16 (0.81%)
Nasdaq 18137.85219.37 (1.22%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI